SmartKem Appoints New CTO and CFO, CFO Departs

TL;DR

SmartKem brings in a new CTO and CFO, while the old CFO exits.

AI Summary

SmartKem, Inc. announced on June 14, 2024, the appointment of Dr. Simon Eldridge as Chief Technology Officer and Mr. David J. Miller as Chief Financial Officer. The company also reported the departure of Mr. Ian Thomas as Chief Financial Officer. These changes are effective immediately.

Why It Matters

The appointment of new key executives in technology and finance can signal strategic shifts or a strengthening of leadership for future growth and operational efficiency.

Risk Assessment

Risk Level: medium — Changes in key executive positions, especially CFO and CTO, can indicate internal shifts that may impact future performance or strategy.

Key Players & Entities

• SmartKem, Inc. (company) — Registrant
• Dr. Simon Eldridge (person) — Appointed Chief Technology Officer
• Mr. David J. Miller (person) — Appointed Chief Financial Officer
• Mr. Ian Thomas (person) — Departed Chief Financial Officer
• June 14, 2024 (date) — Effective date of appointments and departure

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share SMTK The Nasdaq Stock Mar
• $6 — . The Options have an exercise price of $6.50, the closing price of the Common Sto
• $26,767 — Jenks and Ms. Keck in amounts equal to $26,767 and $45,000, respectively, in light of
• $45,000 — s. Keck in amounts equal to $26,767 and $45,000, respectively, in light of their signif

Filing Documents

• tm2417371d1_8k.htm (8-K) — 25KB
• 0001104659-24-072289.txt ( ) — 198KB
• tmb-20240614.xsd (EX-101.SCH) — 3KB
• tmb-20240614_lab.xml (EX-101.LAB) — 33KB
• tmb-20240614_pre.xml (EX-101.PRE) — 22KB
• tm2417371d1_8k_htm.xml (XML) — 4KB

02 Departure

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Option Grants On June 14, 2024, the Compensation Committee of the Board of Directors (the "Compensation Committee") of SmartKem, Inc. (the "Company") approved equity compensation awards for the Company's executive officers. The Compensation Committee approved an award of options (the "Options") to purchase shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), in the following amounts: Ian Jenks, the Company's Chief Executive Officer, was awarded Options to purchase 181,000 shares of Common Stock, Barbra Keck, the Company's Chief Financial Officer, was awarded Options to purchase 100,000 shares of Common Stock, Simon Ogier, Ph.D., the Company's Chief Technology Officer was awarded Options to purchase 49,000 shares of Common Stock and Beverley Brown, Ph.D., the Company's Chief Scientist, was awarded Options to purchase 49,000 shares of Common Stock. The Options were granted in accordance with the terms of the Company's 2021 Equity Incentive Plan and/or the UK Tax-Advantaged Sub-Plan (the "Plan"). The Options have an exercise price of $6.50, the closing price of the Common Stock on the Nasdaq Capital Market on June 14, 2024 and vested as to 25% upon grant with the remainder in equal monthly installments over three years, except that options to purchase 16,000 shares of Common Stock granted to Mr. Jenks vested immediately upon grant (the "Additional Options"). The Additional Options have an exercise price of $6.50, the closing price of the Common Stock on the Nasdaq Capital Market on June 14, 2024. Uplisting Bonuses On June 14, 2024, the Compensation Committee approved the payment of cash bonuses to Mr. Jenks and Ms. Keck in amounts equal to $26,767 and $45,000, respectively, in light of their significant contributions to the uplisting of the Common Stock to the Nasdaq Capital

View Full Filing

View this 8-K filing on SEC EDGAR